PT100245A - Sequencia de adn que codifica um derivado de factor viii humano recombinante, biologicamente activo, vector de expressao recombinante, celula hospedeira, processo de producao de um derivado de factor vii e derivado de factor viii - Google Patents
Sequencia de adn que codifica um derivado de factor viii humano recombinante, biologicamente activo, vector de expressao recombinante, celula hospedeira, processo de producao de um derivado de factor vii e derivado de factor viiiInfo
- Publication number
- PT100245A PT100245A PT100245A PT10024592A PT100245A PT 100245 A PT100245 A PT 100245A PT 100245 A PT100245 A PT 100245A PT 10024592 A PT10024592 A PT 10024592A PT 100245 A PT100245 A PT 100245A
- Authority
- PT
- Portugal
- Prior art keywords
- derivative
- factor viii
- recombinant
- sequence
- host cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Mold Materials And Core Materials (AREA)
- Molds, Cores, And Manufacturing Methods Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9100799A SE468050C (sv) | 1991-03-15 | 1991-03-15 | Rekombinant derivat av human faktor VIII |
Publications (2)
Publication Number | Publication Date |
---|---|
PT100245A true PT100245A (pt) | 1993-07-30 |
PT100245B PT100245B (pt) | 1999-08-31 |
Family
ID=20382191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT100245A PT100245B (pt) | 1991-03-15 | 1992-03-13 | Sequencia de adn que codifica um derivado de factor viii humano recombinante, biologicamente activo, vector de expressao recombinante, celula hospedeira, processo de producao de um derivado de factor vii e derivado de factor viii |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0533862B1 (pt) |
JP (1) | JP2655752B2 (pt) |
AR (1) | AR247590A1 (pt) |
AT (1) | ATE186055T1 (pt) |
AU (1) | AU650730B2 (pt) |
CA (1) | CA2081659C (pt) |
DE (1) | DE69230206T2 (pt) |
DK (1) | DK0533862T3 (pt) |
ES (1) | ES2137182T3 (pt) |
FI (1) | FI107539B (pt) |
GR (1) | GR3032468T3 (pt) |
IE (1) | IE920814A1 (pt) |
NO (1) | NO308174B1 (pt) |
PT (1) | PT100245B (pt) |
SE (1) | SE468050C (pt) |
WO (1) | WO1992016557A1 (pt) |
ZA (1) | ZA921882B (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5595886A (en) * | 1986-01-27 | 1997-01-21 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
US6060447A (en) * | 1987-05-19 | 2000-05-09 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
US5888974A (en) * | 1992-04-07 | 1999-03-30 | Emory University | Hybrid human/animal factor VIII |
US5663060A (en) * | 1992-04-07 | 1997-09-02 | Emory University | Hybrid human/animal factor VIII |
US5744446A (en) * | 1992-04-07 | 1998-04-28 | Emory University | Hybrid human/animal factor VIII |
US5364771A (en) * | 1992-04-07 | 1994-11-15 | Emory University | Hybrid human/porcine factor VIII |
JP3633933B2 (ja) | 1992-07-31 | 2005-03-30 | アカンビス、リサーチ、リミテッド | 弱毒化細菌における組換え融合タンパク質の発現 |
SE9300509D0 (sv) * | 1993-02-16 | 1993-02-16 | Kabi Pharmacia Ab | Peg treatment |
SE504074C2 (sv) * | 1993-07-05 | 1996-11-04 | Pharmacia Ab | Proteinberedning för subkutan, intramuskulär eller intradermal administrering |
GB9401787D0 (en) * | 1994-01-31 | 1994-03-23 | Medeva Holdings Bv | Vaccine compositions |
SE9303601D0 (sv) * | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Improved cell cultivation method and medium |
SE9403915D0 (sv) * | 1994-11-14 | 1994-11-14 | Annelie Almstedt | Process A |
US6221349B1 (en) | 1998-10-20 | 2001-04-24 | Avigen, Inc. | Adeno-associated vectors for expression of factor VIII by target cells |
US6200560B1 (en) | 1998-10-20 | 2001-03-13 | Avigen, Inc. | Adeno-associated virus vectors for expression of factor VIII by target cells |
US6197526B1 (en) * | 1999-01-04 | 2001-03-06 | Dyax Corp. | Polypeptides for binding human factor VIII and fragments of human factor VIII |
US7112438B2 (en) | 1999-01-04 | 2006-09-26 | Dyax Corp. | Binding molecules for human factor VIII and factor VIII-like proteins |
EP1038959A1 (en) * | 1999-03-17 | 2000-09-27 | Aventis Behring Gesellschaft mit beschränkter Haftung | Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX |
EP1048726B1 (en) * | 1999-04-27 | 2006-07-26 | Négrier, Claude | Modified factor VIII cDNA |
SE9901379D0 (sv) | 1999-04-19 | 1999-04-19 | Pharmacia & Upjohn Ab | Receptor structures |
EP1233064A1 (en) | 2001-02-09 | 2002-08-21 | Aventis Behring Gesellschaft mit beschränkter Haftung | Modified factor VIII cDNA and its use for the production of factor VIII |
EP1284290A1 (en) * | 2001-08-08 | 2003-02-19 | Aventis Behring GmbH | Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA |
EP1283263A1 (en) * | 2001-08-08 | 2003-02-12 | Aventis Behring GmbH | Modified cDNA for high expression levels of factor VIII and its derivatives |
CA3072423A1 (en) | 2003-09-30 | 2005-04-14 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
ES2580044T3 (es) | 2005-04-07 | 2016-08-18 | The Trustees Of The University Of Pennsylvania | Método de incremento de la función de un vector de AAV |
KR20080007226A (ko) * | 2005-04-14 | 2008-01-17 | 체에스엘 베링 게엠베하 | 증가된 안정성을 가진 변형된 응고 인자 ⅷ 및 이의 유도체 |
JP5922095B2 (ja) | 2010-03-29 | 2016-05-24 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 薬理学的に誘導される導入遺伝子アブレーション系 |
US9315825B2 (en) | 2010-03-29 | 2016-04-19 | The Trustees Of The University Of Pennsylvania | Pharmacologically induced transgene ablation system |
BRPI1105317A2 (pt) | 2011-01-24 | 2013-04-30 | Fundacco Hemoct De Ribeirco Preto | produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1 |
US9884071B2 (en) | 2011-02-17 | 2018-02-06 | The Trustees Of The University Of Pennsylvania | Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer |
WO2015012924A2 (en) | 2013-04-29 | 2015-01-29 | The Trustees Of The University Of Pennsylvania | Tissue preferential codon modified expression cassettes, vectors containing same, and use thereof |
CN105017410B (zh) * | 2014-04-18 | 2018-06-08 | 北京诺思兰德生物技术股份有限公司 | 一种b区部分缺失型重组人凝血因子ⅷ |
CN115074366A (zh) | 2015-04-16 | 2022-09-20 | 埃默里大学 | 用于肝脏中蛋白质表达的重组启动子和载体及其用途 |
SG11201902998SA (en) | 2016-10-03 | 2019-05-30 | Daiichi Sankyo Co Ltd | PROMOTER OF Hspa5 GENE |
CA3188420A1 (en) | 2020-08-07 | 2022-02-10 | Joseph Bauman | Vesicle targeting proteins and uses of same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1200773A (en) * | 1980-02-29 | 1986-02-18 | William J. Rutter | Expression linkers |
JPS62181786A (ja) * | 1985-08-12 | 1987-08-10 | シンテツクス(ユ−・エス・エイ)インコ−ポレイテツド | 融合蛋白質の製造法 |
US4935233A (en) * | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
US5451521A (en) * | 1986-05-29 | 1995-09-19 | Genetics Institute, Inc. | Procoagulant proteins |
IL83192A (en) * | 1986-07-18 | 1992-11-15 | Gist Brocades Nv | Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies |
NZ219516A (en) * | 1987-02-10 | 1991-02-26 | Wellcome Found | Fusion proteins of hbcag (hepatitis b virus core antigen) |
DE3720246A1 (de) * | 1987-06-19 | 1988-12-29 | Behringwerke Ag | Faktor viii:c-aehnliches molekuel mit koagulationsaktivitaet |
DK0500734T3 (da) * | 1989-11-17 | 1998-03-30 | Chiron Corp | Proteinkomplekser med faktor VIII:C-aktivitet samt frembringelse deraf |
SE465222C5 (sv) * | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
CA2078721A1 (en) * | 1991-09-24 | 1993-03-25 | Hiroshi Yonemura | Process for preparing human coagulation factor viii protein complex |
-
1991
- 1991-03-15 SE SE9100799A patent/SE468050C/sv not_active IP Right Cessation
-
1992
- 1992-03-11 DE DE69230206T patent/DE69230206T2/de not_active Expired - Lifetime
- 1992-03-11 ES ES92905708T patent/ES2137182T3/es not_active Expired - Lifetime
- 1992-03-11 CA CA002081659A patent/CA2081659C/en not_active Expired - Lifetime
- 1992-03-11 WO PCT/SE1992/000150 patent/WO1992016557A1/en active IP Right Grant
- 1992-03-11 JP JP4505642A patent/JP2655752B2/ja not_active Expired - Lifetime
- 1992-03-11 DK DK92905708T patent/DK0533862T3/da active
- 1992-03-11 EP EP92905708A patent/EP0533862B1/en not_active Expired - Lifetime
- 1992-03-11 AT AT92905708T patent/ATE186055T1/de active
- 1992-03-11 AU AU13513/92A patent/AU650730B2/en not_active Expired
- 1992-03-13 IE IE081492A patent/IE920814A1/en not_active IP Right Cessation
- 1992-03-13 ZA ZA921882A patent/ZA921882B/xx unknown
- 1992-03-13 PT PT100245A patent/PT100245B/pt not_active IP Right Cessation
- 1992-03-13 AR AR92321933A patent/AR247590A1/es active
- 1992-11-11 FI FI925131A patent/FI107539B/fi not_active IP Right Cessation
- 1992-11-13 NO NO924395A patent/NO308174B1/no not_active IP Right Cessation
-
2000
- 2000-01-25 GR GR20000400162T patent/GR3032468T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2655752B2 (ja) | 1997-09-24 |
NO924395D0 (no) | 1992-11-13 |
EP0533862A1 (en) | 1993-03-31 |
CA2081659C (en) | 2002-06-25 |
JPH05507420A (ja) | 1993-10-28 |
SE9100799D0 (sv) | 1991-03-15 |
SE9100799L (sv) | 1992-09-16 |
ATE186055T1 (de) | 1999-11-15 |
AR247590A1 (es) | 1995-01-31 |
GR3032468T3 (en) | 2000-05-31 |
DE69230206D1 (de) | 1999-12-02 |
AU1351392A (en) | 1992-10-21 |
PT100245B (pt) | 1999-08-31 |
FI107539B (fi) | 2001-08-31 |
FI925131A0 (fi) | 1992-11-11 |
DK0533862T3 (da) | 2000-01-17 |
SE468050B (sv) | 1992-10-26 |
WO1992016557A1 (en) | 1992-10-01 |
NO308174B1 (no) | 2000-08-07 |
CA2081659A1 (en) | 1992-09-16 |
EP0533862B1 (en) | 1999-10-27 |
SE468050C (sv) | 1998-04-27 |
ZA921882B (en) | 1992-11-25 |
IE920814A1 (en) | 1992-09-23 |
ES2137182T3 (es) | 1999-12-16 |
FI925131A (fi) | 1992-11-11 |
DE69230206T2 (de) | 2000-05-18 |
NO924395L (no) | 1993-01-13 |
AU650730B2 (en) | 1994-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT100245A (pt) | Sequencia de adn que codifica um derivado de factor viii humano recombinante, biologicamente activo, vector de expressao recombinante, celula hospedeira, processo de producao de um derivado de factor vii e derivado de factor viii | |
DK0559884T4 (da) | Rekombinante virusvektorer til ekspression i muskelceller | |
DE69401230D1 (de) | Verwendung von Polyurethanen, die funktionelle Carboxylatogruppe enthalt, zur Haarfestigung | |
FI20090384A (fi) | Menetelmä modifioidun G-CSF-polypeptidin valmistamiseksi | |
FI100056B (fi) | Ihmisproapolipoproteiinin A-I ilmaiseminen | |
DK122687D0 (da) | Polypeptid, dna og anvendelse deraf | |
PT835261E (pt) | Canal ionico | |
EE200000152A (et) | Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon | |
DK368489D0 (da) | Stabiliserede hydrogenperoxidpraeparater og deres anvendelse | |
NO910982D0 (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
AU3346289A (en) | Heparin-binding proteins, DNA coding for them, processes for producing them as well as therapeutic preparations containing them | |
NO981322L (no) | Farmas÷ytiske preparater for bruk ved nukleinsyretransfeksjon, og deres anvendelse | |
GR3019347T3 (en) | Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity | |
IL88371A0 (en) | Directed integration of genes into a plant genome and recombinant dna,expression vectors and host cells used therefor | |
BR9306150A (pt) | Endo--1,4-glucanase sequéncia de dna recombinante vetor hospedeiro transformado contendo o vetor processo para a produç o de endo- -1,4-glucanase preparaç o de enzima e uso de endo- -1,4-glucanase | |
EP0315118A3 (en) | Dna coding for endothelin and use thereof | |
FR2732978B1 (fr) | Vecteur viral recombinant, composition pharmaceutique le contenant et cellules transformees correspondantes | |
DK0571475T3 (da) | Beta-1,4-galactanase og en DNA-sekvens | |
FI942227A0 (fi) | Menetelmä geenien ilmentämiseksi Bacillus licheniformisissa | |
IL89391A0 (en) | Structural gene coding for an insecticidal endotoxin protein,said protein,its production and use of said gene and protein | |
ES2099304T3 (es) | Mitogeno de la musculatura lisa y adn que lo codifica. | |
PT88098A (pt) | Processo de clonacao e expressao de genes codificando para proteinas constituintes de edificios funcionais organizados | |
BR9507507A (pt) | Polipeptideo proteina para uso como uma toxina sequéncia de nucleotídeos processo para produzir um polipeptideo molécula de dna recombinante vetor de express o célula inseticida sistema inseticida planta animal n o humano toxina processo para produzir um polipeptídeo ativo de um polipeptídeo precursor inativo isolado sequéncia base de nucleotídeos isolada sequéncia base siolada nova toxina poliptídeo isolado e novo assunto ou combinaç o | |
PT84474B (pt) | Processo para a preparacao de uma substancia proteica insecticida | |
IT9041655A0 (it) | Processo per isolamento ed espressione del fattore neuronotrofico ciliare umano mediante la tecnologia del dna ricombinante. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19930322 |
|
FG3A | Patent granted, date of granting |
Effective date: 19990521 |
|
PC3A | Transfer or assignment |
Free format text: 20020108 BIOVITRUM AB SE |
|
PD3A | Change of proprietorship |
Owner name: PHARMACIA AKTIEBOLAG Effective date: 20020108 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20131121 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20140521 |